Joseph Carleone - Apr 28, 2022 Form 4 Insider Report for SENSIENT TECHNOLOGIES CORP (SXT)

Role
Director
Signature
/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone
Stock symbol
SXT
Transactions as of
Apr 28, 2022
Transactions value $
$0
Form type
4
Date filed
5/2/2022, 05:20 PM
Previous filing
Apr 4, 2022
Next filing
Jul 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SXT Common Stock Award $0 +1.06K +6.93% $0.00 16.4K Apr 28, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SXT Deferred Stock 14.5K Apr 28, 2022 Common Stock 14.5K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated.
F2 Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan.
F3 Deferred stock converts to common stock on a one-for-one basis.
F4 Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.